Jul 1

Past Event

Exploring the Promise of Patient Medication Information

Video

Full Event

  • Session I: Lessons Learned from Patient Medication Information Projects

    Moderated by Brookings Fellow, Gregory W. Daniel, experts and researchers from Concentrics Health, Northwestern University, the U.S. Food and Drug Administration, Duke University, PatientsLikeMe, and Adheris Health presented and discussed findings from recent Patient Medication Information (PMI) studies. The studies provided insights on improving patient literacy and comprehension levels; effectively using graphics, icons and other visual formats; and identifying best practices for each PMI prototype.

    Gregory W. Daniel and Mark B. McClellan

  • Session II: Moving Patient Medication Information Forward

    Moderated by Brookings Senior Fellow, Mark McClellan, panelists from CVS Caremark, GlaxoSmithKline, the National Health Council, the National Community Pharmacists Association, and the National Association of Chain Drug Stores provided insights on the future of Patient Medication Information (PMI), and assessed their respective roles in moving the initiative forward.

    Mark B. McClellan

Summary

To view the webcast archive click here.

In order to take their medications safely and effectively, patients need medication information that is accurate, balanced, and delivered in an easily understood format. However, the current sources of written prescription information patients receive are numerous, uncoordinated, and sometimes conflicting.

To address the pressing need for high-quality medication information, the U.S. Food and Drug Administration (FDA), the Engelberg Center for Health Care Reform, and other stakeholders from throughout the biomedical ecosystem have worked over the past several years to establish a new single-document format called Patient Medication Information (PMI). As part of an ongoing cooperative agreement between the Engelberg Center and FDA, this event highlighted progress-to-date on the PMI initiative. Stakeholder helped identify opportunities to improve the clarity and content of consumer medication information; disseminate key takeaways and best practices; and determine next steps for realizing the full potential of PMI.

Event Agenda

  • 9:00 - 9:15

    Welcome and Overview

    • mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Bryon Pearsall

      U.S. Food and Drug Administration (FDA)

  • 9:15 - 10:15

    Lessons Learned from Patient Medication Information Projects

  • 10:15 - 11:00

    Moderated Discussion with Session I Panelists

  • 11:15 - 12:15

    Moving Patient Medication Information Forward

    • Moderator

      mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Marc Boutin

      National Health Council

    • Angela Patterson

      CVS Caremark Minute Clinic

    • Ronna Hauser

      National Community Pharmacists Association

    • Kevin Nicholson

      National Association of Chain Drug Stores

    • Amy Ebel

      GlaxoSmithKline

  • 12:15 - 12:30

    Closing Remarks

    • mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Bryon Pearsall

      U.S. Food and Drug Administration (FDA)

Details

July 1, 2014

9:00 AM - 12:30 PM EDT

Falk Auditorium

1775 Massachusetts Ave., NW

Map

Join the Conversation

#PatientMedInfo

For More Information

Brookings Office of Communications

202.797.6105